PL2364693T3 - Bezwodny wielofazowy układ żelowy - Google Patents

Bezwodny wielofazowy układ żelowy

Info

Publication number
PL2364693T3
PL2364693T3 PL11169258T PL11169258T PL2364693T3 PL 2364693 T3 PL2364693 T3 PL 2364693T3 PL 11169258 T PL11169258 T PL 11169258T PL 11169258 T PL11169258 T PL 11169258T PL 2364693 T3 PL2364693 T3 PL 2364693T3
Authority
PL
Poland
Prior art keywords
gel system
multiphase gel
anhydrous
anhydrous multiphase
multiphase
Prior art date
Application number
PL11169258T
Other languages
English (en)
Inventor
Patrick Franke
Original Assignee
Intendis Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intendis Gmbh filed Critical Intendis Gmbh
Publication of PL2364693T3 publication Critical patent/PL2364693T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0052—Preparation of gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
PL11169258T 2005-08-04 2006-08-04 Bezwodny wielofazowy układ żelowy PL2364693T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005037844A DE102005037844A1 (de) 2005-08-04 2005-08-04 Wasserfreies Mehr-Phasen-Gel-System
EP11169258.8A EP2364693B1 (de) 2005-08-04 2006-08-04 Wasserfreies MehrPhasen-Gel-System
EP06775843.3A EP1912624B1 (de) 2005-08-04 2006-08-04 Wasserfreies mehr-phasen-gel-system

Publications (1)

Publication Number Publication Date
PL2364693T3 true PL2364693T3 (pl) 2015-05-29

Family

ID=37309687

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11169258T PL2364693T3 (pl) 2005-08-04 2006-08-04 Bezwodny wielofazowy układ żelowy

Country Status (17)

Country Link
US (3) US20100166681A1 (pl)
EP (2) EP2364693B1 (pl)
JP (1) JP5563218B2 (pl)
CN (1) CN101511339B (pl)
AU (1) AU2006275206A1 (pl)
CA (1) CA2620451C (pl)
CY (1) CY1116074T1 (pl)
DE (1) DE102005037844A1 (pl)
DK (1) DK2364693T3 (pl)
ES (1) ES2536933T3 (pl)
IL (1) IL189154A (pl)
NZ (1) NZ565634A (pl)
PL (1) PL2364693T3 (pl)
PT (1) PT2364693E (pl)
RU (1) RU2429815C2 (pl)
SI (1) SI2364693T1 (pl)
WO (1) WO2007014563A2 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
MX2010002592A (es) * 2007-09-10 2010-03-30 Glenmark Pharmaceuticals Ltd Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
CN104138352B (zh) * 2013-04-19 2018-02-27 江苏知原药业有限公司 卡泊三醇非水凝胶
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
EP3237074A1 (en) * 2014-12-23 2017-11-01 Henkel AG & Co. KGaA Multi-layer self-adhesive gel and applicator
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
CN105434199B (zh) * 2015-12-28 2018-06-19 佛山市雅丽诗化妆品股份有限公司 一种双色油彩的生产工艺
IL300437B1 (en) * 2016-01-07 2026-06-01 Viramal Ltd Gel formulations for transdermal drug delivery to maximize drug concentrations in the stratum corneum and serum and methods of using them
RU2754464C2 (ru) 2016-02-22 2021-09-02 Марс, Инкорпорейтед Корм для домашних животных
WO2018046681A1 (en) 2016-09-08 2018-03-15 Bayer Pharma Aktiengesellschaft Forms of 5-{[(1s,2s)-1-(2-chloro-3-fluoro-4-methoxyphenyl)-3,3,3-trifluoro-2-hydroxy-2-(methoxymethyl)propyl]amino}-7-fluoro-1h-quinolin-2-one
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
WO2018046678A1 (de) 2016-09-08 2018-03-15 Bayer Aktiengesellschaft Glukokorticoid-rezeptor-agonisten enthaltende formulierungen
JP7167059B2 (ja) * 2017-04-19 2022-11-08 フィオ ファーマシューティカルズ コーポレーション 核酸化合物の局所送達
DE102017221630A1 (de) * 2017-12-01 2019-06-06 Henkel Ag & Co. Kgaa Restrukturierung von blondierten Haaren durch Mittel mit aliphatischen Polyolen und cyclischen Carbonaten
CN108467464A (zh) * 2018-04-02 2018-08-31 常熟理工学院 含壬二酸可见光固化水凝胶及其制备方法
CN108853312B (zh) * 2018-09-25 2021-04-16 陕西天宇制药有限公司 聚桂醇外用凝胶及其制备方法
AU2019365255B2 (en) 2018-10-26 2025-06-12 Viramal Limited Mucoadhesive gel composition
CN109467696B (zh) * 2018-11-05 2021-08-31 西南林业大学 一种聚酰胺-单宁木材胶粘剂的制备方法
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent
CN110438149A (zh) * 2019-08-08 2019-11-12 天津大学 转LcSABP基因烟草耐三氯生的用途
CN111467258A (zh) * 2020-05-28 2020-07-31 许文斌 一种抗氧化抗衰老的美白凝胶及其制备方法
CN114028325B (zh) * 2021-12-10 2023-08-01 福元药业有限公司 一种他克莫司软膏制剂
CN116850087A (zh) * 2023-07-18 2023-10-10 上海臻臣化妆品有限公司 乙基纤维素凝胶及其制备方法、亮面唇釉

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
FR2631826B1 (fr) * 1988-05-27 1992-06-19 Centre Nat Rech Scient Vecteur particulaire utile notamment pour le transport de molecules a activite biologique et procede pour sa preparation
SE9003706L (sv) * 1990-11-21 1992-05-22 Eva Greijer Metoder foer immobilisering av liposomer i gelkulor, och gelkulor med liposomer vilka immobiliserats med anvaendning av dessa metoder
FR2681248B1 (fr) * 1991-09-13 1995-04-28 Oreal Composition pour un traitement cosmetique et/ou pharmaceutique de longue duree des couches superieures de l'epiderme par une application topique sur la peau.
FR2702160B1 (fr) * 1993-03-02 1995-06-02 Biovecteurs As Vecteurs particulaires synthétiques et procédé de préparation.
SE9402455L (sv) * 1994-07-12 1996-01-13 Karlshamns Lipidteknik Ab Biskiktspreparat
FR2735689B1 (fr) * 1995-06-21 1997-08-01 Oreal Composition comprenant une dispersion de particules de polymeres dans un milieu non aqueux
US6284375B1 (en) * 1996-10-18 2001-09-04 Tuo Jin Lipid vesicle system
US5776494A (en) * 1996-12-20 1998-07-07 The Procter & Gamble Company Pharmaceuticals compositions containing gellants in the form of alkyl amides of di-and tri-carboxylic acids
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
FR2787730B1 (fr) * 1998-12-29 2001-02-09 Oreal Nanocapsules a base de poly(alkylene adipate), leur procede de preparation et compositions cosmetiques ou dermatologiques les contenant
CN1346257A (zh) * 1999-04-07 2002-04-24 西巴特殊化学品控股有限公司 液体分散聚合物组合物,其制备方法及其应用
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
US20020022040A1 (en) * 2000-07-10 2002-02-21 The Proctor & Gamble Company Methods of enhancing delivery of oil-soluble skin care actives
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds
FR2848879A1 (fr) * 2002-12-20 2004-06-25 Oreal Nanocapsules comprenant un polymere silicone de type polysilsesquioxane, composition cosmetique ou pharmaceutique les comprenant, et procede de preparation
US20050013854A1 (en) * 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
US7477940B2 (en) * 2003-06-30 2009-01-13 J&J Consumer Companies, Inc. Methods of administering an active agent to a human barrier membrane with galvanic generated electricity

Also Published As

Publication number Publication date
CA2620451C (en) 2014-11-25
CA2620451A1 (en) 2007-02-08
EP1912624A2 (de) 2008-04-23
CN101511339B (zh) 2013-09-11
US20160361252A1 (en) 2016-12-15
CY1116074T1 (el) 2017-02-08
US20100166681A1 (en) 2010-07-01
AU2006275206A1 (en) 2007-02-08
JP5563218B2 (ja) 2014-07-30
NZ565634A (en) 2011-03-31
RU2008107393A (ru) 2009-09-10
RU2429815C2 (ru) 2011-09-27
IL189154A0 (en) 2008-08-07
SI2364693T1 (sl) 2015-10-30
JP2009502988A (ja) 2009-01-29
EP2364693A2 (de) 2011-09-14
US20140186278A1 (en) 2014-07-03
WO2007014563A3 (de) 2007-04-26
DK2364693T3 (en) 2015-03-30
DE102005037844A1 (de) 2007-04-05
WO2007014563A2 (de) 2007-02-08
PT2364693E (pt) 2015-03-17
ES2536933T3 (es) 2015-05-29
EP2364693B1 (de) 2014-12-17
CN101511339A (zh) 2009-08-19
EP2364693A3 (de) 2013-02-27
IL189154A (en) 2010-11-30
EP1912624B1 (de) 2017-07-19

Similar Documents

Publication Publication Date Title
IL189154A (en) Anhydrous multiphase gel system
IL278979B (en) Pharma-informatics system
EP2061261A4 (en) STEREO PROJECTION SYSTEM
IL183862A0 (en) System
GB0412796D0 (en) Supawall system
GB0502159D0 (en) Videoendoscopic system
EP1708407A4 (en) MixNet SYSTEM
GB2402814B (en) Multi-computer system
EP1865751A4 (en) SURROUND SYSTEM
GB2410560B (en) System
EP1807810A4 (en) CASH HANDLING SYSTEM
GB2431563B (en) Watersport hiking-support system
GB0511518D0 (en) Nofog system
GB0504771D0 (en) System
GB0409627D0 (en) Fabron fabloc system
GB0518674D0 (en) System
GB2408130B (en) Phonecard system
GB2427760B (en) Antenna-transceiver system
GB0514898D0 (en) Introduction system
GB0421161D0 (en) X-plug system
HU0400134V0 (en) Clothing-dryer system
GB0418372D0 (en) Ultra-loc system
GB0418527D0 (en) Nu-sleeve system
GB0419082D0 (en) Floodseal system
GB0406475D0 (en) Soakaway system